Patent Assignment
Reel/Frame 028914/0036
Notice of Change in Registered Office Address
Recorded: 2012-09-05
Pages: 3
Assignor
EDT PHARMA HOLDINGS
Executed: 2011-08-15
Assignee
EDT PHARMA HOLDINGS
MONKSLAND, ATHLONE, CO. WESTMEATH, IRELAND
Covered Properties
(8)
Diltiazem Formulation and Methods of Treatment
Patent:
5,336,504 →
Application:
08/064,401 →
Passive Transdermal Device with Controlled Drug Delivery
Patent:
5,533,995 →
Application:
08/244,094 →
Controlled Release Pharmaceutical Formulation
Patent:
5,505,962 →
Application:
08/307,392 →
Controlled Absorption Diltiazen Formulation for Once-Daily Administration
Patent:
5,616,345 →
Application:
08/334,864 →
Controlled Release Biodegradable Micro-and Nanospheres Containing Cyclosporin
Patent:
5,641,745 →
Application:
08/479,509 →
Multiparticulate modified release composition
Application:
10/827,689 →
Publication:
US 2004/0197405
Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and Entacapone
Application:
11/422,226 →
Publication:
US 2008/0118556
Modified Release Loxoprofen Compositions
Application:
11/568,925 →
Publication:
US 2009/0297602
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement (Second Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Patent Security Agreement (First Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Asset Transfer Agreement
Sep 5, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 028914/0018 →
Notice of Change in Registered Office Address
Sep 5, 2012
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028914/0106 →
Change of Name
Sep 5, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028914/0039 →
Release by Secured Party (Second Lien)
Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Second Amendment to Intellectual Property Transfer and License Agreement
Aug 8, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033500/0707 →
Change of Name
Mar 26, 2015
From: ALKERMES SCIENCE ONE LIMITED
To: DARAVITA LIMITED
Reel/Frame 035264/0078 →
Business Transfer Agreement
Apr 10, 2015
From: DARAVITA LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 035409/0872 →
Asset Transfer and License Agreement
Apr 10, 2015
From: ALKERMES PHARMA IRELAND LIMITED
To: DV TECHNOLOGY LLC
Reel/Frame 035409/0897 →
Security Interest
Apr 14, 2015
From: RECRO TECHNOLOGY LLC
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 035403/0288 →
Change of Name
Apr 16, 2015
From: DV TECHNOLOGY LLC
To: RECRO TECHNOLOGY LLC
Reel/Frame 035446/0904 →
Release of Security Interest
Apr 27, 2015
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: DARAVITA LIMITED (F/K/A ALKERMES SCIENCE ONE LIMITED, SUCCESSOR IN INTEREST TO ALKERMES PHARMA IRELAND LIMITED)
Reel/Frame 035505/0696 →
Merger
Nov 1, 2016
From: RECRO TECHNOLOGY LLC
To: RECRO GAINESVILLE LLC
Reel/Frame 040184/0332 →
Security Interest
Nov 17, 2017
From: RECRO GAINESVILLE LLC
To: ATHYRIUM OPPORTUNITIES III ACQUSITION LP
Reel/Frame 044165/0783 →
Release of Security Interest
Nov 17, 2017
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: RECRO GAINESVILLE LLC (F/K/A RECRO TECHNOLOGY LLC)
Reel/Frame 044164/0008 →
Corrective Assignment to Correct the Receiving Party's Name Previously Recorded at Reel: 044165 Frame: 0783. Assignor(S) Hereby Confirms the Grant of Security Interest .
Mar 8, 2019
From: RECRO GAINESVILLE LLC
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 048540/0737 →
Release of Security Interest
Dec 16, 2022
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: SOCIETAL CDMO GAINESVILLE, LLC
Reel/Frame 062123/0339 →
Release of Patent Security Agreement (First Lien)
Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 069771/0548 →